AMF siRNA treatment of keloid through inhibition signaling pathway of RhoA/ROCK1

Yi Tian, Lan Jin, Wenhong Zhang, Yuan Cheng, Hongyun Zhao

Genes & Diseases · 2018 · 10 citations · 29 references

DOIFull text

Open access

Concepts

Abstract

< 0.05), KD tissue sections stained by HE and Masson showed that fibers became loose and the blood vessels were visibly reduced. In conclusion, AMF siRNA is expected to be a novel strategy to treat KD by inhibiting signaling pathway of RhoA/ROCK1.

References

29